Roman Hovorka, PhD
University of Cambridge
13
7
13
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+11 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Linda DiMeglio, MD
Indiana University
Shared therapeutic areas:
Worked with same sponsors:
Nelly Mauras, MD
Nemours Children's Health System
Shared therapeutic areas:
Worked with same sponsors:
Paul Wadwa, MD
University of Colorado, Denver
Shared therapeutic areas:
Worked with same sponsors:
David Dunger, MD, FRCPCH
University of Cambridge
Shared therapeutic areas:
Worked with same sponsors:
Stuart Weinzimer, MD
Yale University
Shared therapeutic areas:
Worked with same sponsors:
Louise Denvir, MD
Nottingham Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Fiona Campbell, MD, FRCPCH
Leeds Teaching Hospitals
Shared therapeutic areas:
Worked with same sponsors:
Bruce Buckingham, MD
Stanford University
Shared therapeutic areas:
Worked with same sponsors:
Fiona Campbell, MD
The Leeds Teaching Hospitals NHS Trust
Shared therapeutic areas:
Worked with same sponsors:
Nikki C Davis, MD
Southampton Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
Closed-loop in Adults With T2D Not Requiring Dialysis
24/7 Closed-loop in Older Subjects With Type 1 Diabetes
Closed-loop in Adults With T2D Requiring Dialysis
Day and Night Closed-loop in Young People With Type 1 Diabetes
Closing the Loop 24/7 in Adolescents With Type 1 Diabetes
Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes
Achieving Normal Glucose In Hospital Settings
Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing
Closing the Loop in Adolescents During Non-compliance Behaviours
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes
Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting
Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions
Automated Closed-loop in Children and Adolescents With Type 1 Diabetes
All 13 trials loaded